Citations 356

Tocilizumab and Satralizumab in MOGAD: Real-world Outcomes for Relapse Prevention (P3-1.002)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216861

Clinical and Radiologic Spectrum and Outcomes of Myelopathy Associated with Spinal Cord Displacement: A Single-center Cohort Study (P9-7.004)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216805

Safety and Efficacy of Satralizumab in Patients with Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD): Results from the Phase 3 METEOROID Trial (PL5.006)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217915

Myelin Alterations Within and Beyond Lesions in MOG Antibody-associated Disease: Insights from Ultra-high field (7T) MRI (S6.002)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217390

Radiographic Determinants of Serum Neurofilament Light Chain Elevation in Multiple Sclerosis (P8-19.002)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216614

Effectiveness of Infliximab for Refractory Non-ischemic Cerebral Enhancing Foreign-body Granulomatous Lesions Following Endovascular Therapy (P1-1.003)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215791

Frequency of Optic Nerve Enhancement During Acute Optic Neuritis in MOG Antibody-associated Disease (S6.004)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215356

Central Nervous System Restricted Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder in Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder (P4-1.006)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217260

Expanding the Phenotype of MOGAD: Multiple Cranial Neuropathies in a Patient with Seronegative-CSF-positive MOG IgG (P7-1.010)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216382

Impact of MRI Activity and Medical Comorbidities on Serum Neurofilament Light Chain in Multiple Sclerosis (P3-20.004)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215939